Biocon quarterly results and financials

Biocon (BIOCON)₹368.50+0.34%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Biocon reported sales of ₹4,351 Cr, up 10.0% from Jun 2025, and net profit of ₹137 Cr, up 54.0% year on year. For the year to Mar 2026, sales were ₹16,993 Cr and net profit ₹369 Cr.

Sales (Jun 2026): ₹4,351 Cr
Net profit (Jun 2026): ₹137 Cr
Sales (FY Mar 2026): ₹16,993 Cr
Net profit (FY Mar 2026): ₹369 Cr
EPS (Jun 2026): ₹0.88
Borrowings (Mar 2026): ₹15,437 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Biocon quarterly results

₹ crore unless stated; each column is a quarter.

Biocon Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	3,478	3,972	3,934	3,446	3,604	3,837	4,434	3,955	4,315	4,191	4,535	4,351
Expenses	2,744	3,049	3,004	2,808	2,903	3,067	3,335	3,173	3,458	3,339	3,495	3,485
Operating Profit	714	900	910	618	683	750	1,074	764	833	832	1,017	845
OPM %	21.1%	23.0%	23.1%	18.1%	19.1%	20.1%	24.1%	19.1%	19.1%	20.1%	23.1%	20.0%
Other Income	134	588	40.07	1,168	58.06	53.09	57.07	62.10	81.20	−176	−28.03	41.06
Interest	247	266	226	235	225	222	212	276	271	209	231	212
Depreciation	389	414	407	405	420	425	436	455	473	515	513	547
Profit before tax	213	806	318	1,143	97.85	156	486	96.78	171	−67.85	248	128
Tax %	19.0%	6.9%	29.9%	24.9%	72.0%	47.9%	6.0%	8.0%	22.0%	−24.1%	19.9%	−7.0%
Exceptional items	−17.97	18.97	−4.99	23.95	6.98	4.99	18.98	−4.99	−7.99	−225	0.99	−0.99
Net Profit	173	753	223	861	26.99	80.96	459	88.89	133	−51.94	199	137
EPS (Rs)	1.06	5.51	1.14	5.50	−0.14	0.22	2.88	0.24	0.64	1.09	0.79	0.88

Biocon profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Biocon Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	3,362	3,904	4,139	5,533	6,322	7,173	8,219	11,214	14,822	15,319	16,993	17,391
Expenses	2,954	2,908	3,290	4,119	4,696	5,563	6,391	8,764	11,540	11,995	13,452	13,777
Operating Profit	389	977	826	1,389	1,599	1,576	1,788	2,406	3,205	3,243	3,461	3,527
OPM %	12.1%	25.0%	20.1%	25.1%	25.1%	22.1%	22.1%	22.1%	22.1%	21.1%	21.1%	20.3%
Other Income	640	173	228	341	199	260	72.13	18.02	855	1,218	−76.09	−82.16
Interest	28.92	25.94	61.85	70.78	64.84	57.81	67.79	418	972	895	987	924
Depreciation	249	277	385	448	552	715	814	1,114	1,568	1,688	1,958	2,049
Profit before tax	749	848	609	1,213	1,183	1,066	980	896	1,521	1,884	447	478
Tax %	18.9%	19.0%	25.9%	17.0%	26.9%	20.9%	21.9%	27.9%	14.9%	24.0%	17.9%	—
Exceptional items	205	2.99	43.92	180	57.89	10.97	−98.83	−230	43.91	57.92	−2.99	−233
Net Profit	608	687	453	1,003	871	845	772	642	1,297	1,428	369	417
EPS (Rs)	4.60	5.11	3.11	7.56	6.26	6.18	5.41	3.86	8.54	8.46	2.39	3.40
Dividend payout %	17.9%	10.0%	16.0%	7.0%	0.0%	0.0%	8.9%	39.0%	6.0%	6.0%	21.0%	—

Biocon balance sheet

₹ crore, at each year end.

Biocon Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	100	100	100	300	300	601	600	600	600	600	600	810
Reserves	3,163	3,924	4,723	4,870	5,782	6,086	7,008	7,809	17,219	19,136	20,991	33,119
Borrowings	1,119	2,483	2,306	2,269	2,427	2,720	4,489	5,159	18,035	16,289	18,373	15,437
Other Liabilities	1,980	1,938	2,243	2,533	3,657	4,980	6,355	6,731	15,780	19,598	18,445	13,876
Total Liabilities	6,362	8,443	9,372	9,972	12,166	14,387	18,452	20,299	51,634	55,623	58,410	63,243
Fixed Assets	1,626	1,743	3,613	3,687	4,457	5,957	6,346	6,555	29,394	30,566	31,870	36,355
CWIP	1,672	2,232	836	1,300	1,894	2,189	2,790	4,095	7,294	7,964	8,488	6,969
Investments	229	900	1,250	674	1,010	965	1,948	1,584	2,065	998	1,125	1,777
Other Assets	2,835	3,568	3,672	4,311	4,806	5,277	7,369	8,064	12,881	16,096	16,926	18,142
Inventories	452	541	633	720	1,030	1,433	1,862	2,293	4,231	4,932	4,921	6,072
Trade receivables	767	711	880	1,060	1,288	1,219	1,496	2,052	3,558	6,209	5,464	5,964
Cash & equivalents	935	1,534	1,041	1,319	1,055	996	2,010	1,742	2,394	2,253	4,106	3,183
Total Assets	6,362	8,443	9,372	9,972	12,166	14,387	18,452	20,299	51,634	55,623	58,410	63,243

Biocon cash flow

₹ crore, for each year.

Biocon Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	212	372	642	664	1,157	1,286	1,163	1,179	1,856	2,962	4,072	1,998
Cash from investing activity	−492	−1,140	−512	−685	−705	−1,510	−3,660	−1,667	−14,287	−1,004	−204	−1,887
Cash from financing activity	186	1,066	−178	−239	−241	387	2,557	241	13,010	−2,327	−1,848	−921
Net cash flow	−94.05	300	−47.04	−261	210	165	72.05	−243	642	−380	2,005	−813
Capex	839	619	608	917	1,493	1,838	1,747	1,927	1,727	1,931	2,345	1,914
Free cash flow	−626	−245	31.90	−250	−336	−545	−575	−744	129	1,043	1,713	81.80
CFO / OP %	49.0%	157.9%	85.9%	104.0%	103.9%	100.9%	85.9%	80.0%	85.9%	101.0%	138.9%	63.9%

Biocon ratios

Working-capital days and returns, by year.

Biocon Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	91	78	83	94	86	71	77	92	117	154	131	129
Inventory days	132	153	160	161	199	263	304	309	423	368	346	390
Days payable	124	171	186	223	230	242	245	215	382	466	459	433
Cash conversion cycle	99	60	58	32	54	92	135	185	158	56	19	86
Working capital days	−18	−11	25	7	−1	−30	9	72	4	−67	−62	−16
ROCE %	12.1%	9.1%	12.1%	8.1%	13.1%	13.1%	10.1%	9.1%	6.0%	6.0%	6.0%	4.0%

Biocon: frequently asked questions

What are the latest quarterly results of Biocon?

For the Jun 2026 quarter, Biocon reported sales of ₹4,351 Cr, up 10.0% year on year and net profit of ₹137 Cr, up 54.0% year on year. The operating margin was 20.0%.

What is the annual revenue of Biocon?

Biocon's sales for the year to Mar 2026 were ₹16,993 Cr; over the last twelve months they were ₹17,391 Cr.

What is the net profit of Biocon?

Net profit for the year to Mar 2026 was ₹369 Cr, and ₹417 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.40.

How much debt does Biocon have?

Biocon reported borrowings of ₹15,437 Cr at Mar 2026, against cash and equivalents of ₹3,183 Cr.

What is the free cash flow of Biocon?

Cash from operations was ₹1,998 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹81.80 Cr.

Loading…